Impact of Bundled Payments on Care for ESRD Patients

ASN Renal Week 2009 Official Symposium
A. Introduction, Overview of MIPPA, and Explanation of Bundled Payments for ESRD Services
Paul Smedberg, MD, and Jonathan Himmelfarb, MD
B. Controversial aspects of bundling
Jonathan Himmelfarb, MD (Moderator); Raymond Hakim, MD; John Moran, MD; Allen Nissenson, MD; Rajiv Saran, MD; and Wolfgang Winkelmayer, MD
C. Changes triggered by bundling on CKD patients
Jonathan Himmelfarb, MD (Moderator); Raymond Hakim, MD; John Moran, MD; Allen Nissenson, MD; Rajiv Saran, MD; and Wolfgang Winkelmayer, MD
D. Limitation of bundling
Jonathan Himmelfarb, MD (Moderator); Raymond Hakim, MD; John Moran, MD; Allen Nissenson, MD; Rajiv Saran, MD; and Wolfgang Winkelmayer, MD
E. Involvement of the nephrology community in bundling
Jonathan Himmelfarb, MD (Moderator); Raymond Hakim, MD; John Moran, MD; Allen Nissenson, MD; Rajiv Saran, MD; and Wolfgang Winkelmayer, MD
F. Audience Questions and Key Take-Home Points
Jonathan Himmelfarb, MD (Moderator); Raymond Hakim, MD; John Moran, MD; Allen Nissenson, MD; Rajiv Saran, MD; and Wolfgang Winkelmayer, MD

Paul Smedberg, MD (moderator)
Director of Policy and Public Affairs
American Society of Nephrology
Jonathan Himmelfarb, MD (moderator)
Maine Medical Center
Portland, Maine
Raymond Hakim, MD
Clinical and Scientific Affairs for Fresenius Medical Care-NA.
Brentwood, TN
John Moran, MD
Senior Vice President of Clinical Affairs
Satellite Healthcare and WellBound
Allen Nissenson, MD
David Geffen School of Medicine, UCLA
Los Angeles, CA
Rajiv Saran, MD
University of Michigan
Ann Arbor, MI
Wolfgang Winkelmayer, MD
Brigham and Women’s Hospital
Boston, MA
This group of talks is accredited for up to 1.5 AMA PRA Category 1 credits™. This group of talks has a single post-test, which must be completed along with an evaluation form to obtain credit. The links to the post-test appear on the individual talk pages.
Date of Web Release: January 4, 2010
CME Credit Eligible Through: April 30, 2011
AMA PRA Category 1 Credits™: 1.5
Target Audiences: Physicians, Researchers and Fellows-in-Training.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the abstracts linked to post-test answer feedback material.

For the first time in nearly 30 years, the Medicare program is implementing a new system for caring for patients with kidney disease, particularly patients with end-stage renal disease (ESRD). Based on the Medicare Improvements for Patients and Providers Act (MIPPA) of 2008, this system will likely have monumental impact on care for patients with renal disease and on the practice of nephrology nationwide. This symposium will first provide an overview of crucial aspects of MIPPA, focusing on provisions most likely influence care for ESRD patients. An expert panel consisting of policymakers, chief medical officers from dialysis organizations, and world-renowned researchers will then discuss the potential impact of bundling on ESRD care, research and innovation in treating kidney disease, and the future of the practice of nephrology nationwide.

Accreditation Statement
The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME Credit Designation Statement:
The American Society of Nephrology designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in each portion of this activity.

Support for this session is provided by an educational grant from Amgen.

It is the policy of ASN that all individuals in a position to control the content of ASN's sponsored CME activities are expected to provide full disclosure for both themselves and their spouse/partner, and indicate to the activity audience any relevant financial or other relationships held by themselves or their spouse/partner 1) with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial service(s) discussed in an educational presentation; and 2) with any commercial supporter(s) of the activity. All responses should reflect activities within the previous 12 months. This disclosure information is collected in accordance with the Accreditation Council for Continuing Medical Education (ACCME). Further, ASN requires that all faculty disclose at the time of their lecture, any planned discussion of investigational and/or off-label use of pharmaceutical products or devices within their presentation. Participants should note that the use of products outside U.S. Food and Drug Administration (FDA) approved labeling should be considered experimental and are advised to consult current prescribing information for approval indications.

The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in continuing medical education (CME), but rather to ensure that ASN CME activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. In addition, all faculty members were instructed to provide balanced, scientifically rigorous, and evidence-based presentations.

Faculty disclosures are posted on each individual talk page.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The American Society of Nephrology and HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Faculty disclosure about unlabeled or off-label use is posted on each individual talk page.

As a condition of your access and use of the Website, you agree not to use the Website for any purpose that is unlawful or inconsistent with the Agreement. ASN, in its sole discretion, is authorized to remove or delete any entries, information, materials or other content that violates these Terms of Use or that is otherwise objectionable. ASN reserves the right to investigate and prosecute violations of any of these Terms of Use to the fullest extent of the law. If Users fail to comply with these Terms of Use, ASN in its sole discretion may terminate the User's access to the website immediately without advance notice. These terms of use comprise an Agreement that is governed by the laws of the District of Columbia, which shall be the forum for any disputes.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

To complete this educational activity, the user will need Windows (XP or higher) or Macintosh (version 9.0 or higher) operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player, either the Windows Media Player (download from or the Flash version 8.0 (download from is required, and either can be downloaded for free per instructions on the individual lecture pages. Flash version 8.0 is required for the full-screen slide version of the program. Acrobat Reader is required to print the CME certificate, and this can be download free from

For any questions concerning this specific activity please send an email to or, or call HDCN at 630-325-3276 during normal business hours, Chicago time (Central Standard Time).

For any general questions concerning ASN CME, please contact the American Society of Nephrology.